NASDAQ : FLNA
Filana Therapeutics, Inc. — Financial statements
Other · United States
Last price 0.622 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 30.05M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cost of Revenue | 15.65M | 26.59M | 69.64M | 89.42M | 68.03M | 24.81M |
| Gross Profit | -15.65M | -26.59M | -69.64M | -89.42M | -68.03M | -24.81M |
| Selling, General & Admin | -1.98M | 33.50M | 81.71M | 16.63M | 11.99M | 8.05M |
| Operating Expenses | -1.98M | 33.50M | 81.71M | 16.63M | 11.99M | 8.05M |
| Operating Income | -13.67M | -60.09M | -151.35M | -106.06M | -80.02M | -32.87M |
| Interest & Investment Income | 3.68M | 4.62M | 8.51M | 7.83M | 2.78M | 49.00K |
| Other Non Operating Income (Expenses) | 16.00K | -203.00K | 108.59M | 907.00K | 997.00K | 434.00K |
| EBT Excluding Unusual Items | -9.98M | -55.67M | -34.24M | -97.32M | -76.25M | -32.38M |
| Legal Settlements | -32.30M | -35.30M | ||||
| Pretax Income | -42.28M | -90.97M | -24.34M | -97.22M | -76.25M | -32.38M |
| Net Income | -42.28M | -90.97M | -24.34M | -97.22M | -76.25M | -32.38M |
| Net Income to Common | -42.28M | -90.97M | -24.34M | -97.22M | -76.25M | -32.38M |
| Shares Outstanding (Basic) | 48.30M | 48.30M | 46.33M | 41.93M | 40.20M | 39.41M |
| Shares Outstanding (Diluted) | 48.30M | 48.30M | 46.60M | 41.93M | 40.20M | 39.41M |
| EPS (Basic) | -0.88 | -1.88 | -0.53 | -2.32 | -1.90 | -0.82 |
| EPS (Diluted) | -0.88 | -1.88 | -1.46 | -2.32 | -1.90 | -0.82 |
| Free Cash Flow | -29.30M | -32.83M | -117.03M | -82.44M | -80.23M | -52.41M |
| Free Cash Flow Per Share | -0.61 | -0.68 | -2.51 | -1.97 | -2.00 | -1.33 |
| EBITDA | -12.69M | -59.15M | -150.21M | -104.53M | -78.72M | -32.33M |
| D&A For EBITDA | 985.00K | 936.00K | 1.13M | 1.53M | 1.30M | 534.00K |
| EBIT | -13.67M | -60.09M | -151.35M | -106.06M | -80.02M | -32.87M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 82.68M | 95.50M | 128.57M | 121.14M | 201.01M | 233.44M |
| Cash & Short-Term Investments | 82.68M | 95.50M | 128.57M | 121.14M | 201.01M | 233.44M |
| Other Receivables | 120.00K | 947.00K | 962.00K | |||
| Receivables | 120.00K | 947.00K | 962.00K | |||
| Prepaid Expenses | 14.00K | 493.00K | 800.00K | 759.00K | 874.00K | 662.00K |
| Other Current Assets | 1.03M | 1.59M | 6.21M | 6.78M | 9.34M | 10.38M |
| Total Current Assets | 83.72M | 97.71M | 136.53M | 129.63M | 211.23M | 244.48M |
| Property, Plant & Equipment | 20.18M | 20.45M | 20.96M | 21.85M | 22.99M | 20.83M |
| Other Intangible Assets | 193.00K | 37.00K | 176.00K | 622.00K | 1.07M | |
| Other Long-Term Assets | 399.00K | |||||
| Total Assets | 103.90M | 118.36M | 157.53M | 151.66M | 234.83M | 266.78M |
| Accounts Payable | 8.04M | 10.40M | 6.65M | 10.57M | 4.02M | 7.13M |
| Accrued Expenses | 838.00K | 2.17M | 4.05M | 3.58M | 2.45M | 4.68M |
| Current Portion of Leases | 104.00K | 97.00K | ||||
| Other Current Liabilities | 31.28M | 31.27M | 1.04M | 47.00K | 492.00K | 631.00K |
| Total Current Liabilities | 40.16M | 43.83M | 11.75M | 14.20M | 7.06M | 12.53M |
| Long-Term Leases | 35.00K | 139.00K | ||||
| Other Long-Term Liabilities | 136.00K | 118.00K | 79.00K | 197.00K | 194.00K | |
| Total Liabilities | 40.29M | 43.95M | 11.83M | 14.20M | 7.29M | 12.87M |
| Common Stock | 48.00K | 48.00K | 48.00K | 42.00K | 42.00K | 40.00K |
| Additional Paid-In Capital | 578.58M | 570.44M | 550.77M | 518.20M | 511.05M | 461.18M |
| Retained Earnings | -515.02M | -496.08M | -405.11M | -380.77M | -283.55M | -207.31M |
| Shareholders' Equity | 63.61M | 74.40M | 145.70M | 137.47M | 227.54M | 253.91M |
| Total Liabilities & Equity | 103.90M | 118.36M | 157.53M | 151.66M | 234.83M | 266.78M |
| Total Debt | 139.00K | 236.00K | ||||
| Net Cash (Debt) | 82.68M | 95.50M | 128.57M | 121.14M | 200.88M | 233.20M |
| Net Cash Per Share | 1.71 | 1.98 | 2.76 | 2.89 | 5.00 | 5.92 |
| Filing Date Shares Outstanding | 48.31M | 48.31M | 48.31M | 43.23M | 41.74M | 40.02M |
| Total Common Shares Outstanding | 48.31M | 48.31M | 48.20M | 42.24M | 41.74M | 40.02M |
| Working Capital | 43.56M | 53.88M | 124.78M | 115.44M | 204.16M | 231.95M |
| Book Value Per Share | 1.32 | 1.54 | 3.02 | 3.25 | 5.45 | 6.35 |
| Tangible Book Value | 63.61M | 74.21M | 145.67M | 137.29M | 226.92M | 252.84M |
| Tangible Book Value Per Share | 1.32 | 1.54 | 3.02 | 3.25 | 5.44 | 6.32 |
| Land | 3.73M | 3.73M | 3.73M | 3.73M | 3.73M | 3.73M |
| Buildings | 15.98M | 15.98M | 15.98M | 15.98M | 15.98M | 15.98M |
| Machinery | 891.00K | 891.00K | 875.00K | 868.00K | 851.00K | 178.00K |
| Construction In Progress | 25.00K | 55.00K | 13.00K | 83.00K | ||
| Leasehold Improvements | 3.52M | 3.47M | 3.06M | 3.06M | 3.02M | 567.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -42.28M | -90.97M | -24.34M | -97.22M | -76.25M | -32.38M |
| Depreciation & Amortization | 985.00K | 936.00K | 1.13M | 1.53M | 1.30M | 534.00K |
| Stock-Based Compensation | 17.92M | 19.58M | 16.29M | 4.59M | 2.07M | 1.76M |
| Other Operating Activities | -108.18M | |||||
| Change in Accounts Payable | -3.53M | 33.99M | -2.92M | 6.90M | -3.45M | 6.21M |
| Change in Other Net Operating Assets | -1.79M | 4.21M | 1.09M | 2.18M | -1.19M | -6.32M |
| Operating Cash Flow | -28.70M | -32.25M | -116.93M | -82.03M | -77.51M | -30.20M |
| Capital Expenditures | -602.00K | -581.00K | -103.00K | -414.00K | -2.71M | -22.21M |
| Investing Cash Flow | -602.00K | -581.00K | -103.00K | -414.00K | -2.71M | -22.21M |
| Issuance of Common Stock | 90.00K | 124.47M | 2.56M | 47.80M | 192.34M | |
| Other Financing Activities | -396.00K | -329.00K | ||||
| Financing Cash Flow | -396.00K | -239.00K | 124.47M | 2.56M | 47.80M | 192.34M |
| Net Cash Flow | -29.70M | -33.07M | 7.44M | -79.88M | -32.42M | 139.93M |
| Free Cash Flow | -29.30M | -32.83M | -117.03M | -82.44M | -80.23M | -52.41M |
| Free Cash Flow Per Share | -0.61 | -0.68 | -2.51 | -1.97 | -2.00 | -1.33 |
| Levered Free Cash Flow | 3.98M | 20.22M | -79.18M | -51.63M | -54.00M | -40.39M |
| Unlevered Free Cash Flow | 3.98M | 20.22M | -79.18M | -51.63M | -54.00M | -40.39M |
| Change in Working Capital | -5.32M | 38.20M | -1.83M | 9.08M | -4.63M | -104.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 27.24M | 95.65M | 113.54M | 949.34M | 1.23B | 1.75B |
| Enterprise Value | -55.45M | -10.43M | -35.44M | 806.99M | 1.06B | 1.51B |
| Last Close Price | 0.62 | 1.98 | 2.36 | 22.51 | 29.54 | 43.70 |
| Forward PE | 69.70 | 69.70 | 68.21 | 20.01 | 27.14 | |
| PB Ratio | 0.47 | 1.29 | 0.78 | 6.91 | 5.42 | 6.89 |
| P/TBV Ratio | 0.47 | 1.29 | 0.78 | 6.92 | 5.43 | 6.92 |
| Debt / Equity Ratio | 0.00 | 0.00 | ||||
| Net Debt / Equity Ratio | -1.30 | -1.28 | -0.88 | -0.88 | -0.88 | -0.92 |
| Net Debt / EBITDA Ratio | 6.52 | 1.61 | 0.86 | 1.16 | 2.55 | 7.21 |
| Net Debt / FCF Ratio | 2.82 | 2.91 | 1.10 | 1.47 | 2.50 | 4.45 |
| Quick Ratio | 2.06 | 2.18 | 11.02 | 8.60 | 28.46 | 18.62 |
| Current Ratio | 2.08 | 2.23 | 11.62 | 9.13 | 29.91 | 19.51 |
| Return on Equity (ROE) | -55.78% | -82.66% | -17.19% | -53.27% | -31.67% | -18.71% |
| Return on Assets (ROA) | -7.14% | -27.23% | -61.19% | -34.30% | -19.94% | -11.38% |
| Return on Capital Employed (ROCE) | -21.40% | -80.60% | -103.80% | -77.20% | -35.10% | -12.90% |
| Earnings Yield | -155.27% | -95.11% | -21.44% | -10.24% | -6.19% | -1.85% |
| FCF Yield | -97.53% | -34.33% | -103.08% | -8.68% | -6.51% | -3.00% |
| Buyback Yield / Dilution | -0.24% | -3.63% | -11.14% | -4.30% | -2.02% | -50.95% |